← FDA DRUG APPROVALS

FDA ANDA · ANDA063021

KANAMYCIN SULFATE

Sponsor: LOCH

APPLICATION
ANDA063021
TYPE
ANDA
ORIGINAL APPROVAL
1992-07-31
LATEST ACTION
1992-07-31
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

KANAMYCIN SULFATEDiscontinued
KANAMYCIN SULFATE EQ 75MG BASE/2ML · INJECTABLE · INJECTION

Approval history

1992-07-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →